For instance, in vivo activation of NK cells using cytokine treatments (e.g., IL2, IL12, IL15, IL18 and IL21) has been investigated in several types of mouse cancer models and human cancers [180,181,182,183]. This evidence concerns the gene IL15 and cancer.